Growth in India’s dental market is being driven by increasing oral health awareness and rising demand for aesthetic and restorative treatments. (Image: Miguel Serrano/Adobe Stock)
MUMBAI, India: Envista Holdings Corp. has launched Kerr consumables in India, underscoring the growing importance of the country’s dental market and the company’s heightened focus on Asia. The launch, attended by CEO Paul Keel, came one week after Envista opened a new manufacturing facility in Suzhou in China, linking commercial expansion with increased production in the region.
Envista CEO Paul Keel at the launch of Kerr consumables in India. (Image: Envista Holdings)
The company said in a press release that growth in India’s dental market was being driven by increasing oral health awareness and rising demand for aesthetic and restorative treatments. Keel explained at the launch that India is one of Envista’s strategic growth markets and that its growing dental infrastructure and demand for high-quality restorative treatments present significant opportunities. He said: “The launch of Kerr is an important milestone in our commitment to India, where we are making significant investments to ensure our customers can provide better patient care.”
Jay Issa, senior vice-president overseeing Envista’s markets outside North America and Europe, said the development marked a new commitment to Indian dental professionals. He commented: “As we establish our presence in India, we are focused on building lasting relationships through quality products, education, scientific collaboration and strong partnerships with universities, professional organisations and industry partners.” Envista now plans to strengthen its presence in the country through greater engagement with clinicians and a multi-city roadshow featuring international dental experts.
Envista opens new manufacturing hub in Suzhou
In August, the company inaugurated its new US$149 million (€131 million*) manufacturing facility in Suzhou, an industrial hub in Jiangsu province located west of Shanghai. Production at the site officially began on 25 August.
The facility brings production for Ormco, Nobel Biocare and DEXIS under one roof, covering orthodontics, implantology and diagnostics. Notably, Nobel Biocare implants and Ormco orthodontic brackets will be manufactured locally for the first time, and the site will also manufacture aligners and intra-oral scanning devices.
In August, Envista inaugurated its new state-of-the-art manufacturing facility in Suzhou in China. (Image: Envista Holdings)
Dental Tribune International has previously reported on the growing importance of Chinese dental implants sales for international manufacturers, owing to government-led bulk procurement of immense volumes, albeit at a substantially lower unit price. Envista said in August that the second round of contracts for dental implants and the first for orthodontic products were expected to be completed in the second half of this year. The company plans to participate in procurement processes for aligners as well as brackets and wires.
Keel explained to the English-language China Daily that demographic changes and increasing affluence and consumer sophistication were driving Envista’s long-term confidence in China. He also emphasised the manufacturing capabilities available in the country: “We did not invest here because of lower-cost labour or construction materials. We came here because it is a more capable manufacturing environment,” Keel told the newspaper.
LEIPZIG, Germany: First-quarter results from four of the dental industry’s largest manufacturers suggest that the global dental market entered 2026 on ...
MELVILLE, N.Y., US: Henry Schein, the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, has announced the...
LEIPZIG, Germany: In the third financial quarter of this year, hints of improvement in the US dental market were welcomed by the world’s largest dental ...
BREA, Calif., US: Envista Holdings has appointed Paul Keel as its new CEO and a member of its board of directors, effective from 1 May. The company owns ...
BASEL, Switzerland: Straumann Group has announced the appointment of Christopher Norbye as CEO, effective from 1 December, as part of a planned leadership ...
Education
Live webinar Thu. 17 September 2026 12:00 pm EST (New York)
XI’AN, China: In tooth autotransplantation, research has explored the use of robotic systems to prepare recipient sockets to closely match donor root ...
ATHENS, Greece: The research base for 3D printing of definitive restorations is fragmented across material classes, printing technologies and restoration ...
Computer-assisted implant surgery (CAIS) is no longer a single technology but a workflow centred on the digital treatment plan and involving several ...
Brazil / Brasil
Canada / Canada
Latin America / Latinoamérica
USA / USA
Austria / Österreich
Bosnia and Herzegovina / Босна и Херцеговина
Bulgaria / България
Croatia / Hrvatska
Czech Republic & Slovakia / Česká republika & Slovensko
France / France
Germany / Deutschland
Greece / ΕΛΛΑΔΑ
Hungary / Hungary
Italy / Italia
Netherlands / Nederland
Nordic / Nordic
Poland / Polska
Portugal / Portugal
Romania & Moldova / România & Moldova
Slovenia / Slovenija
Serbia & Montenegro / Србија и Црна Гора
Spain / España
Switzerland / Schweiz
Turkey / Türkiye
UK & Ireland / UK & Ireland
China / 中国
India / भारत गणराज्य
Pakistan / Pākistān
Vietnam / Việt Nam
ASEAN / ASEAN
Israel / מְדִינַת יִשְׂרָאֵל
Algeria, Morocco & Tunisia / الجزائر والمغرب وتونس
Middle East / Middle East
Dr. Marko AhonenRegister now1CELive webinar
Dr. Steven VorholtRegister now1.5CELive webinar
Dr. Mona Eide
To post a reply please login or register